Evidence map›Paper›PMID 12704153›Full record

ArticleInfection and immunity2003

Modulation of myosin light-chain phosphorylation by p21-activated kinase 1 in Escherichia coli invasion of human brain microvascular endothelial cells.

Rajyalakshmi S Rudrabhatla, Sunil K Sukumaran, Gary M Bokoch, Nemani V Prasadarao

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. PAK1 as a therapeutic target.Expert opinion on therapeutic targets · 2010
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Rajyalakshmi S RudrabhatlaDivision of Infectious Diseases, Childrens Hospital Los Angeles and Keck School of Medicine, University of Southern California, Los Angeles, California 90027, USA.
Sunil K Sukumaran
Gary M Bokoch
Nemani V Prasadarao
Children's Hospital of Los Angeles · USScripps Research Institute · USUniversity of Southern California · US

Funding

Brain Endothelial Receptor for E. coliR01AI040567 · NIAID · CHILDREN'S HOSPITAL OF LOS ANGELES · PI DAVIS, MARK E, GODDARD, WILLIAM ANDREW · 2001 to 2015
$5.5M
RHO GTPASES IN ADHESION/CHEMOATTRACTANT RECEPTOR CROSSTR01GM044428 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI DERMARDIROSSIAN, CELINE · 1991 to 2010
$4.4M
BRAIN ENDOTHELIAL GLYCOPROTEIN INTERACTIVE WITH E COLIR29AI040567 · NIAID · CHILDREN'S HOSPITAL LOS ANGELES · PI NEMANI, PRASADARAO V · 1997 to 2001
$211k
Role of Complement Proteins in E. coli MeningitisR03HD041525 · NICHD · CHILDREN'S HOSPITAL LOS ANGELES · PI NEMANI, PRASADARAO V · 2002 to 2003
$150k
NIAID NIH HHS AI40567NIAID NIH HHS R01 AI040567NIAID NIH HHS R29 AI040567NICHD NIH HHS HD41525NIGMS NIH HHS GM44428NIGMS NIH HHS R01 GM044428
6 · The paper itself

Abstract

Cytoskeletal dynamics, modulated by actin-myosin interactions, play an important role in Escherichia coli K1 invasion of human brain microvascular endothelial cells (HBMEC). Herein, we show that inhibitors of myosin function, butanedione monoxide and ML-7, significantly blocked the E. coli invasion of HBMEC. The invasive E. coli induces myosin light-chain (MLC) phosphorylation during the invasion process, which gets recruited to the site of actin condensation beneath the bacteria. We also show that invading E. coli downregulates the activity of p21-activated kinase 1 (PAK1), which is an upstream regulator of MLC kinase (MLCK). Overexpression of wild-type PAK1 and constitutively active PAK1 in HBMEC inhibits E. coli invasion significantly with a concomitant decrease in MLC phosphorylation. The inhibition of E. coli invasion by these PAK1 mutants is due to the absence of phospho-MLC at the actin condensation points. In contrast, the dominant-negative PAK1 shows no effect either on the invasion or on MLC phosphorylation or phospho-MLC recruitment to the actin focal points, suggesting that activated PAK1 inactivates MLCK. Taken together, these results suggest that E. coli invasion of HBMEC induces MLC phosphorylation by inhibiting the activity of PAK1 and the recruitment of phosphorylated MLC to the site of actin condensation beneath the bacteria for efficient internalization of E. coli into HBMEC.

Indexed as

ActinsBrainCells, CulturedDown-RegulationEndothelium, VascularEscherichia coliFocal Adhesion Kinase 1Focal Adhesion Protein-Tyrosine KinasesHumansMyosin Light Chainsp21-Activated KinasesPhosphorylationProtein Kinase CProtein Kinase C-alphaProtein Serine-Threonine KinasesProtein-Tyrosine KinasesActinsFocal Adhesion Kinase 1Focal Adhesion Protein-Tyrosine KinasesMyosin Light Chainsp21-Activated KinasesPAK1 protein, humanProtein Kinase CProtein Kinase C-alphaProtein Serine-Threonine KinasesProtein-Tyrosine KinasesPTK2 protein, human

Identifiers

PMID12704153
PMCPMC153270
OpenAlexW2107142302

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.